Nothing new here, just a repeat of previous presentations point for point. Gary should just voiceover his PowerPoint presentation and email it in. Lots of short term speculation conspicuous in the share price.
IMO 3 options going into next year
SNT partners for 1 indication ( Parkinson's, Scarring or Myleo )
SNT partners with company ABC after some or all phase 2 results, shareholder dilutive as with ARIX previously
SNT receives no direct funding / partnership & has to undertake another dilutive capital raising to move to Phase 3 for some of these drug candidates
Speculative is a good description when you consider funding past June 2025
Ann: SNT to present in MST Access Hidden Gems Webinar, page-35
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
-0.001(3.70%) |
Mkt cap ! $31.04M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.8¢ | 2.5¢ | $45.27K | 1.734M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 121728 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 148236 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| SNT (ASX) Chart |